Combination therapy with rituximab and fludarabine in Waldenstrom's Macroglobulinemia.

被引:6
|
作者
Treon, SP
Branagan, A
Wasi, P
Emmanouilides, CA
Frankel, SR
Lister, A
Morel, P
Matous, J
Enschede, SH
Kimby, E
机构
[1] Dana Farber Canc Inst, Bing Program Waldenstroms Macrolgobulinemia, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] McMaster Univ, Med Ctr, Hamilton, ON, Canada
[4] Univ Calif Los Angeles, Ctr Med, Los Angeles, CA 90024 USA
[5] Greenbaum Canc Ctr, Baltimore, MD USA
[6] St Bartholomews Hosp & Canc Res, London, England
[7] Ctr Hosp Schaffner, Lens, France
[8] Mt Canc Ctr, Denver, CO USA
[9] Rush Presbyterian Med Ctr, Chicago, IL USA
[10] Karolinska Inst, Stockholm, Sweden
关键词
D O I
10.1182/blood.V104.11.753.753
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
753
引用
收藏
页码:215A / 215A
页数:1
相关论文
共 50 条
  • [1] Combination therapy with rituximab and fludarabine is highly active in Waldenstrom's macroglobulinemia.
    Treon, SP
    Wasi, P
    Emmanouilides, CA
    Frankel, SR
    Kimby, E
    Lister, A
    Morel, P
    Kelliher, A
    Branagan, A
    Preffer, F
    Anderson, KC
    [J]. BLOOD, 2002, 100 (11) : 211A - 211A
  • [2] Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenstrom's Macroglobulinemia
    Tedeschi, Alessandra
    Ricci, Francesca
    Goldaniga, Maria Cecilia
    Benevolo, Giulia
    Varettoni, Marzia
    Motta, Marina
    Pioltelli, Pietro
    Gini, Guido
    Barate', Claudia
    Luraschi, Annamaria
    Vismara, Eleonora
    Frustaci, Anna Maria
    Nichelatti, Michele
    Vitolo, Umberto
    Baldini, Luca
    Morra, Enrica
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (02): : 231 - 234
  • [3] Prospective evaluation of rituximab for the treatment of Waldenstrom's macroglobulinemia.
    Dimopoulos, MA
    Kiamouris, C
    Karkantaris, C
    Mitsouli, C
    Viniou, N
    [J]. BLOOD, 2000, 96 (11) : 169A - 169A
  • [4] Waldenstrom's macroglobulinemia.
    Finkel, HE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10): : 784 - 784
  • [5] Waldenstrom's macroglobulinemia.
    Wulf, G
    Pool, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11): : 816 - 816
  • [6] Waldenstrom's macroglobulinemia.
    Ilinca-Pruzan, C
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 : 47 - 47
  • [7] Fludarabine therapy in Waldenstrom's macroglobulinemia
    Thalhammer-Scherrer, R
    Geissler, K
    Schwarzinger, I
    Chott, A
    Gisslinger, H
    Knöbl, P
    Lechner, K
    Jäger, U
    [J]. ANNALS OF HEMATOLOGY, 2000, 79 (10) : 556 - 559
  • [8] Phenotypic and clinical evidence supports rituximab for Waldenstrom's macroglobulinemia.
    Weber, DM
    Gavino, M
    Huh, Y
    Cabanillas, F
    Alexanian, R
    [J]. BLOOD, 1999, 94 (10) : 125A - 125A
  • [9] Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenstrom Macroglobulinemia Patients
    Xu, XiaoWei
    Wang, Chun
    Wang, YaMin
    Zhou, LiLi
    Bai, HaiTao
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (04) : 422 - 423
  • [10] Waldenstrom's macroglobulinemia. Current developments in diagnostics and therapy
    Grunenberg, A.
    Buske, C.
    [J]. INTERNIST, 2016, 57 (03): : 238 - +